Article ID Journal Published Year Pages File Type
5673134 Journal of Virological Methods 2017 7 Pages PDF
Abstract
The results of this study showed that EBOV spiked into human serum was not fully inactivated when treated with either 0.1% (v/v) Triton X-100 for 10 mins or 1.0% (v/v) Triton X-100 for 20 mins (final concentrations 0.08% and 0.8% Triton X-100 respectively). AVL alone also did not consistently provide complete inactivation. Samples treated with both AVL and 0.1% Triton X-100 for 10 or 20 mins were shown to be completely inactivated. This treatment is compatible with downstream analysis by RT-qPCR and next generation sequencing.
Related Topics
Life Sciences Immunology and Microbiology Virology
Authors
, , , , , , , , ,